89 related articles for article (PubMed ID: 1965621)
1. Liposomes from soya phospholipids as percutaneous drug carriers. 2nd communication: quantitative in vivo investigations with radioactively labelled liposomes.
Artmann C; Röding J; Ghyczy M; Pratzel HG
Arzneimittelforschung; 1990 Dec; 40(12):1365-8. PubMed ID: 1965621
[TBL] [Abstract][Full Text] [Related]
2. Liposomes from soya phospholipids as percutaneous drug carriers. 1st communication: qualitative in vivo investigations with antibody-loaded liposomes.
Artmann C; Röding J; Ghyczy M; Pratzel HG
Arzneimittelforschung; 1990 Dec; 40(12):1363-5. PubMed ID: 2095134
[TBL] [Abstract][Full Text] [Related]
3. Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactively labelled vesicles.
Fresta M; Puglisi G
J Drug Target; 1996; 4(2):95-101. PubMed ID: 8894969
[TBL] [Abstract][Full Text] [Related]
4. Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes.
Song YK; Kim CK
Biomaterials; 2006 Jan; 27(2):271-80. PubMed ID: 16039711
[TBL] [Abstract][Full Text] [Related]
5. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
Padamwar MN; Pokharkar VB
Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
[TBL] [Abstract][Full Text] [Related]
6. Vesicular carriers for dermal drug delivery.
Sinico C; Fadda AM
Expert Opin Drug Deliv; 2009 Aug; 6(8):813-25. PubMed ID: 19569979
[TBL] [Abstract][Full Text] [Related]
7. Physical stability of liposomes prepared from milk fat globule membrane and soya phospholipids.
Thompson AK; Haisman D; Singh H
J Agric Food Chem; 2006 Aug; 54(17):6390-7. PubMed ID: 16910735
[TBL] [Abstract][Full Text] [Related]
8. PG-liposomes: novel lipid vesicles for skin delivery of drugs.
Elsayed MM; Abdallah OY; Naggar VF; Khalafallah NM
J Pharm Pharmacol; 2007 Oct; 59(10):1447-50. PubMed ID: 17910822
[TBL] [Abstract][Full Text] [Related]
9. In-vivo studies on dexamethasone sodium phosphate liposomes.
Al-Muhammed J; Ozer AY; Ercan MT; Hincal AA
J Microencapsul; 1996; 13(3):293-306. PubMed ID: 8860685
[TBL] [Abstract][Full Text] [Related]
10. Effect of vehicle on topical liposomal drug delivery: petrolatum bases.
Foldvari M
J Microencapsul; 1996; 13(5):589-600. PubMed ID: 8864995
[TBL] [Abstract][Full Text] [Related]
11. Inducing effect of liposomalization on the transdermal delivery of hydrocortisone: creation of a drug supersaturated state.
Barichello JM; Handa H; Kisyuku M; Shibata T; Ishida T; Kiwada H
J Control Release; 2006 Sep; 115(1):94-102. PubMed ID: 16919352
[TBL] [Abstract][Full Text] [Related]
12. Biofunctional textiles prepared with liposomes: in vivo and in vitro assessment.
Martí M; Martínez V; Rubio L; Coderch L; Parra JL
J Microencapsul; 2011; 28(8):799-806. PubMed ID: 21970657
[TBL] [Abstract][Full Text] [Related]
13. The effect of liposomal incorporation of topically applied hydrocortisone on its serum concentration and urinary excretion.
Wohlrab W; Lasch J
Dermatol Monatsschr; 1989; 175(6):348-52. PubMed ID: 2759315
[TBL] [Abstract][Full Text] [Related]
14. [Effect of liposome on permeability and drug retention of sodium fluorescein in rat skin: an experimental study].
Xie YS; Zeng K; Li GF; Dong P; Shi YM; Zhu XL; Sun LD; Hou GR
Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):110-3. PubMed ID: 12581954
[TBL] [Abstract][Full Text] [Related]
15. In vivo comparison of various liposome formulations for cosmetic application.
Betz G; Aeppli A; Menshutina N; Leuenberger H
Int J Pharm; 2005 May; 296(1-2):44-54. PubMed ID: 15885454
[TBL] [Abstract][Full Text] [Related]
16. Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers.
Paolino D; Lucania G; Mardente D; Alhaique F; Fresta M
J Control Release; 2005 Aug; 106(1-2):99-110. PubMed ID: 15935505
[TBL] [Abstract][Full Text] [Related]
17. Liposomes as carriers for dermal delivery of tretinoin: in vitro evaluation of drug permeation and vesicle-skin interaction.
Sinico C; Manconi M; Peppi M; Lai F; Valenti D; Fadda AM
J Control Release; 2005 Mar; 103(1):123-36. PubMed ID: 15710506
[TBL] [Abstract][Full Text] [Related]
18. Current progress and future prospects of liposomes in dermal drug delivery.
Moghimi SM; Patel HM
J Microencapsul; 1993; 10(2):155-62. PubMed ID: 8331490
[TBL] [Abstract][Full Text] [Related]
19. The liposomal formulation of doxorubicin.
Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
[TBL] [Abstract][Full Text] [Related]
20. Lipid vesicles for skin delivery of drugs: reviewing three decades of research.
Elsayed MM; Abdallah OY; Naggar VF; Khalafallah NM
Int J Pharm; 2007 Mar; 332(1-2):1-16. PubMed ID: 17222523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
